Methodology for Clinical Trials Involving Patients with Cancer Who Have Febrile Neutropenia: Updated Guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with Emphasis on Outpatient Studies-Reference-Cited by-同舟云学术

Methodology for Clinical Trials Involving Patients with Cancer Who Have Febrile Neutropenia: Updated Guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with Emphasis on Outpatient Studies

Published:2002-12-15 Issue:12 Volume:35 Page:1463-1468
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Feld Ronald,Paesmans Marianne,Freifeld Alison G.,Klastersky Jean,Pizzo Philip A.,Rolston Kenneth V. I.,Rubenstein Edward,Talcott James A.,Walsh Thomas J.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/35/12/1463/1013549/35-12-1463.pdf

Reference18 articles.

1. Reporting the results of randomized trials of empiric antibiotics in febrile neutropenic patients--a critical survey.

2. A method for assessing the quality of a randomized control trial

3. From the Immunocompromised Host Society: The Design, Analysis, and Reporting of Clinical Trials on the Empirical Antibiotic Management of the Neutropenic Patient: Report of a Consensus Panel

4. Evaluation of New Anti-Infective Drugs for the Treatment of Febrile Episodes in Neutropenic Patients

5. An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT;HEALTH TECHNOL ASSES;2024

2. Chemotherapy-induced febrile neutropenia in a Tunisian Department of Pediatric Oncology;PAN AFR MED J;2022

3. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial;Trials;2020-05-27

4. Evaluation of a 0.75 × 10 9 /L absolute neutrophil count cut‐off for antimicrobial prophylaxis in canine cancer chemotherapy patients;Veterinary and Comparative Oncology;2019-10-16

5. Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA;Systematic Reviews;2019-04-03